Kathryn L. Gilroy

Garscube Estate
Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer.

Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer.

Journal: iScience
Published: December 15, 2025

WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer.

WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer.

Journal: EMBO reports
Published: July 18, 2025

Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

Journal: British journal of cancer
Published: April 10, 2025

Correction: Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-Specific Neutrophils.

Correction: Characterizing Neutrophil Subtypes in Cancer Using scRNA Sequencing Demonstrates the Importance of IL1β/CXCR2 Axis in Generation of Metastasis-Specific Neutrophils.

Journal: Cancer research communications
Published: March 21, 2025

Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.

Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.

Journal: Aging cell
Published: January 10, 2025

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Journal: Nature
Published: December 10, 2024

In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

Journal: Cancer immunology research
Published: December 03, 2024

Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Journal: Nature genetics
Published: June 03, 2024

Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Journal: Nature genetics
Published: February 08, 2024

Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.

Development and Characterisation of a New Patient-Derived Xenograft Model of AR-Negative Metastatic Castration-Resistant Prostate Cancer.

Journal: Cells
Published: December 22, 2023

Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Journal: Cancer research
Published: September 14, 2023

KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.

KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition.

Journal: Cancer research
Published: September 06, 2023
Showing 1-12 of 43

Last Updated: 09/26/2026